Your browser doesn't support javascript.
loading
Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.
Budzik, Jonathan M; Jarlsberg, Leah G; Higashi, Julie; Grinsdale, Jennifer; Hopewell, Phil C; Kato-Maeda, Midori; Nahid, Payam.
Afiliação
  • Budzik JM; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
  • Jarlsberg LG; Division of Pulmonary and Critical Care Medicine, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Higashi J; Tuberculosis Control Unit, San Francisco Department of Public Health, San Francisco, California, United States of America.
  • Grinsdale J; Tuberculosis Control Unit, San Francisco Department of Public Health, San Francisco, California, United States of America.
  • Hopewell PC; Division of Pulmonary and Critical Care Medicine, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Kato-Maeda M; Division of Pulmonary and Critical Care Medicine, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Nahid P; Division of Pulmonary and Critical Care Medicine, Curry International Tuberculosis Center, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
PLoS One ; 9(4): e95645, 2014.
Article em En | MEDLINE | ID: mdl-24759760

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinamida / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2014 Tipo de documento: Article